Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids.

A. L. Brackenridge; N. Jackson; W. Jefferson; M. Stolinski; F. Shojaee-Moradie; R. Hovorka; A. M. Umpleby; D. Russell-Jones

doi:10.1111/j.1464-5491.2009.02729.x

Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids.

A. L. Brackenridge
, N. Jackson
, W. Jefferson
, M. Stolinski
, F. Shojaee-Moradie
, R. Hovorka
, A. M. Umpleby
, D. Russell-Jones

Research output: Contribution to journal › Article › peer-review

Abstract

In patients with Type 2 diabetes and normal lipids, treatment with rosiglitazone or pioglitazone had no significant effect on lipoprotein metabolism compared with placebo.

Original language	English
Pages (from-to)	532-539
Journal	Diabetic Medicine
Volume	26
Issue number	5
DOIs	https://doi.org/10.1111/j.1464-5491.2009.02729.x
Publication status	Published - May 2009

Keywords

Allied health professions and studies

Access to Document

10.1111/j.1464-5491.2009.02729.x

http://dx.doi.org/10.1111/j.1464-5491.2009.02729.x

Cite this

@article{c3d60a4b6eeb4e9db68bbd84d0740f4f,

title = "Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids.",

abstract = "In patients with Type 2 diabetes and normal lipids, treatment with rosiglitazone or pioglitazone had no significant effect on lipoprotein metabolism compared with placebo.",

keywords = "Allied health professions and studies",

author = "Brackenridge, \{A. L.\} and N. Jackson and W. Jefferson and M. Stolinski and F. Shojaee-Moradie and R. Hovorka and Umpleby, \{A. M.\} and D. Russell-Jones",

year = "2009",

month = may,

doi = "10.1111/j.1464-5491.2009.02729.x",

language = "English",

volume = "26",

pages = "532--539",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

TY - JOUR

T1 - Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids.

AU - Brackenridge, A. L.

AU - Jackson, N.

AU - Jefferson, W.

AU - Stolinski, M.

AU - Shojaee-Moradie, F.

AU - Hovorka, R.

AU - Umpleby, A. M.

AU - Russell-Jones, D.

PY - 2009/5

Y1 - 2009/5

N2 - In patients with Type 2 diabetes and normal lipids, treatment with rosiglitazone or pioglitazone had no significant effect on lipoprotein metabolism compared with placebo.

AB - In patients with Type 2 diabetes and normal lipids, treatment with rosiglitazone or pioglitazone had no significant effect on lipoprotein metabolism compared with placebo.

KW - Allied health professions and studies

U2 - 10.1111/j.1464-5491.2009.02729.x

DO - 10.1111/j.1464-5491.2009.02729.x

M3 - Article

SN - 0742-3071

VL - 26

SP - 532

EP - 539

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 5

ER -

Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids.

Abstract

Keywords

Access to Document

Fingerprint

Cite this